In the BioHarmony Drug Report Database

"Preview" Icon

Insulin glargine

Basaglar, Lantus, Semglee, Toujeo, Optisulin (insulin glargine) is a protein pharmaceutical. Insulin glargine was first approved as Basaglar on 2000-04-20. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.

 

Trade Name

 

Lantus, Optisulin, Toujeo
 

Common Name

 

insulin glargine
 

ChEMBL ID

 

CHEMBL1201497
 

Indication

 

diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus
 

Drug Class

 

Image (chem structure or protein)

Insulin glargine structure rendering